2.40

0.00% 0.00

After Hours: 2.42 0.02 +0.83%

Jasper Therapeutics Inc (JSPR)

Overview News Price History Option Chain Financials Discussions Forecast

Jasper Therapeutics Inc stock is traded at $2.40, with a volume of 219.18K. It is up +0.00% in the last 24 hours and down -1.23% over the past month. Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Previous Close:

$2.40

Open:

$2.43

24h Volume:

219.18K

Relative Volume:

0.69

Market Cap:

$39.01M

Revenue:

Net Income/Loss:

$-64.47M

P/E Ratio:

-0.388

EPS:

-6.1852

Net Cash Flow:

$-52.33M

1W Performance:

+0.00%

1M Performance:

-1.23%

6M Performance:

-42.31%

1Y Performance:

-84.01%

1-Day Range:

$2.34

$2.43

1-Week Range:

$2.29

$2.5699

52-Week Range:

$2.215

$26.05

Jasper Therapeutics Inc Stock (JSPR) Company Profile

Name

Jasper Therapeutics Inc

Sector

Healthcare (1142)

Industry

Biotechnology (639)

Phone

(650) 549-1400

Address

2200 BRIDGE PKWY SUITE #102, REDWOOD CITY

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

JSPR's Discussions on Twitter

Compare JSPR with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
JSPR Jasper Therapeutics Inc	2.40	67.02M	0	-64.47M	-52.33M	-6.1852
VRTX Vertex Pharmaceuticals Inc	407.37	104.55B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	464.95	60.36B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	557.73	59.84B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	799.56	49.07B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	327.03	35.16B	4.56B	-176.77M	225.30M	-1.7177

Jasper Therapeutics Inc Stock (JSPR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-08-25	Downgrade	BMO Capital Markets	Outperform → Market Perform
Jul-08-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Jul-07-25	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jul-07-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-13-25	Initiated	UBS	Buy
Dec-06-24	Initiated	BMO Capital Markets	Outperform
Sep-09-24	Initiated	JMP Securities	Mkt Outperform
Jul-08-24	Initiated	BTIG Research	Buy
Jun-27-24	Initiated	Stifel	Buy
May-06-24	Initiated	H.C. Wainwright	Buy
Apr-03-24	Initiated	Evercore ISI	Outperform
Mar-28-24	Initiated	RBC Capital Mkts	Outperform
Mar-18-24	Initiated	TD Cowen	Outperform
Aug-11-23	Initiated	CapitalOne	Overweight
Feb-28-22	Initiated	Cantor Fitzgerald	Overweight
Nov-08-21	Initiated	Credit Suisse	Outperform
Oct-21-21	Initiated	William Blair	Outperform
Oct-20-21	Initiated	BMO Capital Markets	Outperform
Oct-13-21	Initiated	Oppenheimer	Outperform

View All

Jasper Therapeutics Inc Stock (JSPR) Latest News

02:35 AM

Celldex Therapeutics: Caution Warranted After Big Rebound (Rating Downgrade) (NASDAQ:CLDX) - Seeking Alpha

02:35 AM

02:34 AM

Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain OfficersJSPR - PR Newswire

02:34 AM

Oct 12, 2025

JSPR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper - GlobeNewswire

Oct 12, 2025

JSPR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper - GlobeNewswire Inc.

Oct 12, 2025

Oct 11, 2025

Bragar Eagel & Squire, P.C. Reminds Investors of Jasper, KBR, Spirit Aviation, and Molina to Contact the Firm About their Rights in Filed Class Action Lawsuits - GlobeNewswire

Oct 11, 2025

Oct 10, 2025

Deadline Alert: Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire

Oct 10, 2025

JSPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Jasper Therapeutics, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FinancialContent

Oct 10, 2025

Positive Signs As Multiple Insiders Buy Jasper Therapeutics Stock - Yahoo Finance

Oct 10, 2025

Oct 09, 2025

Portnoy Law Firm Announces Class Action on Behalf of Jasper Therapeutics, Inc. Investors - GlobeNewswire

Oct 09, 2025

JSPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Jasper Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Oct 09, 2025

What analysts say about Jasper Therapeutics Inc Equity Warrant stockCup and Handle Formations & Rapid Capital Trading Tips - earlytimes.in

Oct 09, 2025

Oct 08, 2025

DEADLINE ALERT for CYTK, NX, JSPR, and KBR: The Law Offices - GlobeNewswire

Oct 08, 2025

JSPR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper - GlobeNewswire

Oct 08, 2025